5/19/2020Innovent and MD Anderson Announce Partnership to Develop anti-PD-1 The...

5/19/2020Qingdao Primedicine and Primary Peptides Enter Exclusive China Partner...

5/18/2020GSK Granted Clinical Trial Approval of ICOS mAb with Keytruda for HNSC...

5/15/2020Recent Executive Moves

5/15/2020Kangmei Pharma Fined $84,600 for $12.6B Fraud

5/14/2020Consumption Patterns of Chinese Public Medical Institution Drug Sales ...

5/14/2020Snapshot of BMI System Financial Performance in Q1/2020

5/14/2020China's Role in The Global Biotechnology Sector and Implications for U...

5/14/2020Novocure's Optune Approved for Glioblastoma in China

5/14/2020Innovent/Eli Lilly Announce Positive Outcome of TYVYT (Sintilimab Inj)...

5/14/2020Leading Performance Review of Chinese CRO and CDMO/CMO Sector in 2019

5/14/2020Takeda's ADC Drug Adcetris Approved for Marketing in China

5/13/2020CDE Solicits Comments on Draft Guideline on Adaptive Designs for Clini...

5/13/2020CDE Issues Notice on Adjustment of the Submission Time and Form of Imp...

5/12/2020NHSA Issues Notice Requiring BMI Agencies to Settle with Designated Pr...

5/12/2020Herbalmax to Invest $150M in Biotech Project in Wuxi

5/11/2020Simcere Pharma and Primary Peptides Inc. Announce Exclusive China Part...

5/11/2020Novartis Granted Chinese Approval for Multiple Sclerosis Treatment May...

5/11/2020312 A Share-Listed Chinese MedPharm Cos Report 2019 and Q1/2020 Perfor...

5/8/2020CDE Solicits Comments on the Technical Guidelines for Testing of MRD i...

5/8/2020CDE Issues the Technical Guidelines for Study of TSNA Impurities in Ch...

5/8/2020Recent Executive Moves

5/8/2020Junshi Bio Announces Chinese sNDA for Toripalimab in Urothelial Carcin...

5/7/2020Antengene Announces Expansion of Partnership with Karyopharm in Asia P...

5/6/2020Zai Lab's NDA for Omadacycline Granted Priority Review by the CDE

5/6/2020Korean Companies Hope to Win BTX Approvals in China This Year

5/5/2020Uni-Bio and Ypsomed to Co-develop 2nd Generation Diabetes and Osteopor...

5/5/2020Sales Expenditures of Listed Chinese Pharma Cos Up 11% in 2019

5/5/2020Ascentage's HQP1351 Granted Orphan Drug Designation by the USFDA

5/4/2020U.S.-China ESRC Hearing: China's Evolving Healthcare System

Page:121/361 Total number of articles:10820: [First][<<] [119] [120] [121] [122] [123] [>>] [End]